Five Prime Therapeutics, Inc. Restructuring Costs
Five Prime Therapeutics, Inc. reported Restructuring Costs of -$2.74 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2021-03-22
- Five Prime Therapeutics, Inc. restructuring costs for the quarter ending 2020-12-31 was $510.00K, a 89.20% decline year-over-year.
- Five Prime Therapeutics, Inc. restructuring costs for the quarter ending 2020-09-30 was $515.00K.
- Five Prime Therapeutics, Inc. restructuring costs for the quarter ending 2020-06-30 was -$4.77M.
- Five Prime Therapeutics, Inc. restructuring costs for the quarter ending 2020-03-31 was $1.00M, a 46.96% decline year-over-year.
- Five Prime Therapeutics, Inc. restructuring costs for fiscal 2020 was -$2.74M, a 141.44% decline from fiscal 2019.
- Five Prime Therapeutics, Inc. restructuring costs for fiscal 2019 was $6.62M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2020-12-31 | $510.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $1.02M derived: sum of 2 quarters · filed 2021-03-22 | -$3.75M derived: sum of 3 quarters · filed 2021-03-22 | -$2.74M 10-K · filed 2021-03-22 |
| 2020-09-30 | $515.00K 10-Q · filed 2020-11-03 | -$4.25M derived: sum of 2 quarters · filed 2020-11-03 | -$3.25M 10-Q · filed 2020-11-03 | $1.47M derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-06-30 | -$4.77M 10-Q · filed 2020-08-06 | -$3.77M 10-Q · filed 2020-08-06 | $956.00K derived: sum of 3 quarters · filed 2021-03-22 | $956.00K derived: sum of 4 quarters · filed 2021-03-22 |
| 2020-03-31 | $1.00M 10-Q · filed 2020-05-07 | $5.73M derived: sum of 2 quarters · filed 2021-03-22 | $5.73M derived: sum of 3 quarters · filed 2021-03-22 | $5.73M derived: sum of 4 quarters · filed 2021-03-22 |
| 2019-12-31 | $4.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $4.72M derived: sum of 2 quarters · filed 2021-03-22 | $4.72M derived: sum of 3 quarters · filed 2021-03-22 | $6.62M 10-K · filed 2021-03-22 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $0.00 derived: sum of 2 quarters · filed 2020-11-03 | $1.89M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.89M 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | $1.89M 10-Q · filed 2020-05-07 |